Heidelberg Pharma AG (FRA:HPHA)
Germany · Delayed Price · Currency is EUR 2.760
-0.010 (-0.36%)
At close: Jan 30, 2026
Heidelberg Pharma AG Cash Flow Statement
Financials in millions EUR. Fiscal year is December - November.
Millions EUR. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 |
Net Income | -26.18 | -19.38 | -20.35 | -19.7 | -26.14 | -18.37 |
Depreciation & Amortization | 0.84 | 0.84 | 0.82 | 0.68 | 0.75 | 0.72 |
Other Amortization | 0.04 | 0.04 | 0.05 | 0.08 | 0.06 | 0.01 |
Loss (Gain) From Sale of Assets | 0.07 | 0.06 | 0.07 | -0.01 | 0.01 | 0.09 |
Loss (Gain) From Sale of Investments | - | - | -4.75 | - | - | - |
Loss (Gain) on Equity Investments | - | - | - | - | 0.01 | 0.07 |
Stock-Based Compensation | 0.5 | 0.91 | 0.96 | 0.55 | 0.69 | 0.57 |
Other Operating Activities | -2.87 | -0.06 | -0.12 | -0.33 | 0.46 | 0.01 |
Change in Accounts Receivable | -0.02 | 0.69 | 0.12 | -0.08 | 0.17 | 0.04 |
Change in Inventory | -3.91 | -1.33 | -5.9 | -3.84 | -0.52 | 0.01 |
Change in Accounts Payable | 0.43 | -2.33 | 2.12 | 2.15 | -1.91 | 1.8 |
Change in Unearned Revenue | -2.37 | -4.93 | -4.79 | 10.41 | 0.26 | -1.92 |
Change in Other Net Operating Assets | 1.79 | -4.1 | -1.91 | 1.24 | -0.45 | -0.93 |
Operating Cash Flow | -31.66 | -29.59 | -33.67 | -8.86 | -26.61 | -17.89 |
Capital Expenditures | -0.34 | -0.46 | -0.94 | -0.58 | -1.24 | -1.37 |
Sale of Property, Plant & Equipment | -0.01 | 0.03 | 0.03 | 0.02 | - | 0.2 |
Sale (Purchase) of Intangibles | -0.02 | -0.02 | -0.02 | -0.03 | -0.15 | -0.06 |
Investment in Securities | - | - | 6.78 | - | -0.01 | -0.06 |
Other Investing Activities | - | - | 0 | - | - | -0 |
Investing Cash Flow | -0.36 | -0.45 | 5.85 | -0.6 | -1.4 | -1.29 |
Short-Term Debt Issued | - | - | - | 5 | 10 | - |
Total Debt Issued | - | - | - | 5 | 10 | - |
Short-Term Debt Repaid | - | -5 | -10 | - | - | - |
Long-Term Debt Repaid | - | -0.11 | -0.11 | -0.09 | -0.1 | -0.09 |
Total Debt Repaid | -0.07 | -5.11 | -10.11 | -0.09 | -0.1 | -0.09 |
Net Debt Issued (Repaid) | -0.07 | -5.11 | -10.11 | 4.91 | 9.9 | -0.09 |
Issuance of Common Stock | 23.15 | 22.76 | 0.06 | 79.91 | 20.02 | 14.45 |
Other Financing Activities | -4.67 | -1.58 | -0 | -0.82 | -0.75 | -0.06 |
Financing Cash Flow | 18.4 | 16.08 | -10.05 | 84 | 29.17 | 14.29 |
Foreign Exchange Rate Adjustments | -0.08 | -0.06 | -0.01 | 0.65 | 0 | -0.01 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | - |
Net Cash Flow | -13.7 | -14.02 | -37.89 | 75.19 | 1.16 | -4.9 |
Free Cash Flow | -32 | -30.04 | -34.61 | -9.45 | -27.85 | -19.26 |
Free Cash Flow Margin | -1053.39% | -438.64% | -351.07% | -51.03% | -1369.57% | -222.24% |
Free Cash Flow Per Share | -0.68 | -0.65 | -0.74 | -0.25 | -0.86 | -0.64 |
Cash Interest Paid | 0.01 | 0.79 | 0.91 | 0.53 | 0.03 | 0.01 |
Levered Free Cash Flow | -22.31 | -23.51 | -21.5 | -7.26 | -18.84 | -12.83 |
Unlevered Free Cash Flow | -22.3 | -23.42 | -21.02 | -6.74 | -18.53 | -12.82 |
Change in Working Capital | -4.09 | -11.99 | -10.36 | 9.88 | -2.45 | -1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.